KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Share-based Compensation (2017 - 2025)

Elanco Animal Health's Share-based Compensation history spans 9 years, with the latest figure at $16.0 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 6.67% year-over-year to $16.0 million; the TTM value through Dec 2025 reached $68.0 million, up 23.64%, while the annual FY2025 figure was $68.0 million, 23.64% up from the prior year.
  • Share-based Compensation for Q4 2025 was $16.0 million at Elanco Animal Health, down from $17.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $20.0 million in Q2 2025 and bottomed at $9.0 million in Q2 2023.
  • The 5-year median for Share-based Compensation is $15.0 million (2021), against an average of $14.7 million.
  • The largest annual shift saw Share-based Compensation soared 100.0% in 2021 before it tumbled 47.06% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $18.0 million in 2021, then decreased by 16.67% to $15.0 million in 2022, then changed by 0.0% to $15.0 million in 2023, then changed by 0.0% to $15.0 million in 2024, then grew by 6.67% to $16.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Share-based Compensation are $16.0 million (Q4 2025), $17.0 million (Q3 2025), and $20.0 million (Q2 2025).